Scrambler Therapy in Treating Pain and Peripheral Neuropathy in Patients Previously Treated With Chemotherapy
NCT01347723 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 194
Last updated 2020-05-14
Summary
This pilot clinical trial studies scrambler therapy in treating pain and peripheral neuropathy in patients previously treated with chemotherapy. Scrambler therapy may help relieve pain from peripheral neuropathy caused by chemotherapy
Conditions
Interventions
- OTHER
-
scrambler therapy
Undergo scrambler therapy
- OTHER
-
questionnaire administration
Ancillary studies
- PROCEDURE
-
management of therapy complications
Undergo scrambler therapy
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Charles Loprinzi · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-03-31
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- United States
Study Locations
More Related Trials
-
Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy.
NCT06914557 ·Status: RECRUITING ·Phase: PHASE2
-
Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy
NCT00952848 ·Status: COMPLETED ·Phase: PHASE2
-
MC-5A for Chemotherapy Induced Peripheral Neuropathy
NCT01261780 ·Status: COMPLETED ·Phase: PHASE2
-
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
NCT04560673 ·Status: RECRUITING ·Phase: PHASE2
-
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
NCT00471445 ·Status: COMPLETED ·Phase: PHASE3
-
Scrambler Trial for Pain in NMOSD
NCT03452176 ·Status: COMPLETED ·Phase: NA
-
Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
NCT00068445 ·Status: COMPLETED ·Phase: PHASE3
-
MC5-A Scrambler Therapy for the Treatment of Chronic Neuropathic Extremity Pain
NCT02701075 ·Status: UNKNOWN ·Phase: NA
-
Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study
NCT06121232 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Helping Cancer Patients Manage Neuropathy Symptoms From Chemotherapy With a Low-Intensity, Low-Risk Cranial PEMF Device
NCT07061769 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Scrambler Therapy for Corticobasal Syndrome-Associated Pain
NCT05653778 ·Status: RECRUITING ·Phase: NA
-
Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer
NCT00281853 ·Status: COMPLETED
-
Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
NCT01316744 ·Status: UNKNOWN ·Phase: PHASE3
-
Axon Therapy and Conventional Medical Management for Painful Diabetic Neuropathy Compared to Sham and Conventional Medical Management
NCT05620225 ·Status: COMPLETED ·Phase: NA
-
Clinical Effect of LG Medipain for Managing Chronic Pain Disorders
NCT05165901 ·Status: RECRUITING ·Phase: NA
-
Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy in Cancer Patients
NCT06834685 ·Status: RECRUITING ·Phase: NA
-
Fingolimod in Treating Patients With Chemotherapy-Induced Neuropathy
NCT03943498 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
NCT00516503 ·Status: COMPLETED ·Phase: PHASE3
-
Menthol In Neuropathy Trial
NCT04276727 ·Status: COMPLETED ·Phase: PHASE2
-
SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
NCT06480786 ·Status: RECRUITING ·Phase: NA
-
Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy
NCT05388058 ·Status: COMPLETED ·Phase: PHASE2
-
Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy
NCT06389721 ·Status: RECRUITING
-
Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain
NCT07264920 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Photobiomodulation Therapy Using the Realief Therapy System for the Treatment of Chemotherapy-associated Peripheral Neuropathy
NCT02000908 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Neuropathy
NCT05935956 ·Status: COMPLETED